Mednet Logo
HomeQuestion

For patients with solitary plasmacytoma of the ureter undergoing definitive XRT (40-50 Gy), what dose constraint do you use for the ureter?

3 Answers
Mednet Member
Mednet Member
Radiation Oncology · University Hospital Basel

Well, since this is a solitary plasmocytoma of the ureter, I presume that parts of the GTV encompass the OAR here.

I do not think that you can set any meaningful constraint for the ureter, bearing in mind that this is a serial OAR. You can try to avoid hotspots in the ureter, but that's about it.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Vanderbilt-Ingram Cancer Center

Ureteral stenosis is a relatively rare (or, potentially, under-reported) side effect of radiation and is seen most frequently at dose/fractionation schemes much higher than the doses mentioned in the OP.

The below paper shows that the risk of stenosis to a point regarding procedural intervention (G3)...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Marshfield Clinic - Rice Lake

Rectal fields, prostate fields, endometrial fields, and bladder fields, all can deliver 45-50 Gy to the ureter without ureteral stenosis/stricture being a common side effect. There shouldn't be any reason then that there would be such a side effect treating to the same dose for plasmacytoma, which i...

Register or Sign In to see full answer

For patients with solitary plasmacytoma of the ureter undergoing definitive XRT (40-50 Gy), what dose constraint do you use for the ureter? | Mednet